EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Distinct Epidemiology and Temporal Trends of Multidrug-Resistant Organisms in a Newly Established Hospital: A Five-Year Surveillance Study

Xiaoju Ma iD, Zhanjie Li, Zhaofan Luo, Yan Lu, Mingming Chen, Runhan Huang, Xinhai Zhao iD, Li Du, Huiping Huang, Youpeng Chen

Antibiotics · 27.08.2026 · 15 (9) · 834

DOI: 10.3390/antibiotics15090834 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Antibiotics, online erschienen am 27.08.2026. Verfasst von Xiaoju Ma und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Affairs, The Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen 518107, China. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Clinical Research Fund of The Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen Clinical Research Center for Gastroenterology (Gastrointestinal Surgery), National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Antimicrobial resistance is a major global health challenge, with multidrug-resistant organisms (MDROs) emerging faster than new antimicrobial agents are being developed. The epidemiology of MDROs varies substantially across healthcare settings; however, newly established hospitals remain understudied. This study aimed to characterise the epidemiology and temporal trends of MDROs in a newly established tertiary hospital.

Methods

A five-year retrospective longitudinal surveillance study was conducted from 2019 to 2023 in a newly established tertiary hospital in Southern China. Clinical isolates were collected from intensive care unit (ICU) and non-ICU wards. Nine major MDROs were investigated, including extended-spectrum β-lactamase-producing Klebsiella pneumoniae (ESBL-KP) and Escherichia coli (ESBL-ECO); carbapenem-resistant Klebsiella pneumoniae (CRKP), Escherichia coli (CRECO), Acinetobacter baumannii (CRAB), and Pseudomonas aeruginosa (CRPA); methicillin-resistant Staphylococcus aureus (MRSA); and vancomycin-resistant Enterococcus faecium (VREfm) and Enterococcus faecalis (VREfa).

Results

A total of 1533 MDRO isolates were identified during the study period. The predominant pathogens were ESBL-ECO (48.1%), ESBL-KP (16.4%), MRSA (11.4%), and CRPA (11.1%). Most isolates were recovered from non-ICU wards (85.4%), and more than half (51.5%) were community-onset. Isolation rates of ESBL-ECO, CRECO, CRAB, and CRPA were significantly higher in the ICU than in non-ICU wards (all p < 0.05). The incidence density rate of hospital-acquired infections caused by ESBL-KP, CRAB, and CRPA was also significantly higher in the ICU (all p < 0.05). Longitudinal analysis revealed divergent trends among MDROs. While most MDRO isolation rates remained below provincial and national benchmark levels, CRKP and CRAB showed significant increasing trends. CRPA exhibited a distinct pattern, increasing rapidly during the early years after hospital opening, exceeding both provincial and national benchmarks by the second year and remaining elevated thereafter.

Conclusions

MDRO epidemiology during the first five complete calendar years after hospital opening was characterised by a predominance of ESBL-ECO, ESBL-KP, MRSA, and CRPA, together with substantial non-ICU and community-onset burdens and heterogeneous temporal patterns across organisms. CRPA increased rapidly and remained above the available external benchmark thereafter. These findings highlight the need for hospital-wide, organism-specific MDRO surveillance, while maintaining intensified infection prevention and control in ICUs and continued vigilance for carbapenem-resistant pathogens, particularly CRPA.

Schlagwörter

Stichwörter der Autor:innen

antimicrobial resistancecarbapenem-resistant Pseudomonas aeruginosahospital epidemiologyinfection prevention and controlmultidrug-resistant organismsnewly established hospital

Autor:innen und Institutionen

  • Department of Medical Affairs, The Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen 518107, China.
  • Department of Epidemiology and Health Statistics, School of Public Health, Fudan University, Shanghai 200032, China.
  • Department of Infection Control, The First Affiliated Hospital with Nanjing Medical University, Nanjing 210029, China.
  • Department of Clinical Medical Laboratory, The Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen 518107, China.
  • Department of Patient Experience, The Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen 518107, China.
  • Department of Infectious Diseases, The Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen 518107, China.

ORCID-Profile: Xiaoju Ma, Xinhai Zhao

Förderung

  • Clinical Research Fund of The Seventh Affiliated Hospital, Sun Yat-sen University
  • Shenzhen Clinical Research Center for Gastroenterology (Gastrointestinal Surgery)
  • National Natural Science Foundation of China

Zitieren

APA

Ma, X., Li, Z., Luo, Z., Lu, Y., Chen, M., Huang, R., Zhao, X., Du, L., Huang, H., & Chen, Y. (2026). Distinct Epidemiology and Temporal Trends of Multidrug-Resistant Organisms in a Newly Established Hospital: A Five-Year Surveillance Study. Antibiotics, 15(9), 834. https://doi.org/10.3390/antibiotics15090834

Vancouver

Ma X, Li Z, Luo Z, Lu Y, Chen M, Huang R, et al. Distinct Epidemiology and Temporal Trends of Multidrug-Resistant Organisms in a Newly Established Hospital: A Five-Year Surveillance Study. Antibiotics. 2026;15(9):834. doi:10.3390/antibiotics15090834

BibTeX
@article{Ma2026,
  author = {Ma, Xiaoju and Li, Zhanjie and Luo, Zhaofan and Lu, Yan and Chen, Mingming and Huang, Runhan and Zhao, Xinhai and Du, Li and Huang, Huiping and Chen, Youpeng},
  title = {Distinct Epidemiology and Temporal Trends of Multidrug-Resistant Organisms in a Newly Established Hospital: A Five-Year Surveillance Study},
  journal = {Antibiotics},
  year = {2026},
  volume = {15},
  number = {9},
  pages = {834},
  doi = {10.3390/antibiotics15090834}
}
Kostenlos starten →